By continuing to use Wound Care Today site, you agree to the use of cookies. You can change this and find out more by following this link

Accept Cookies >

LBF No Sting Barrier Film and Barrier Cream Range

Description


The LBF No Sting Barrier Film and Barrier Cream product range is specifically designed to deal with the factors that can affect skin integrity including:

  • Exposure to bodily fluids such as urine, faeces, exudate and excessive perspiration
  • Regular changing of adhesive dressings and tapes
  • Friction damage from clothes or bedding rubbing against the skin.

The range includes the following products:

LBF Barrier Cream contains dimethicone and is formulated to provide a barrier between intact skin and urine and faeces. It is designed to be an easy-to-apply formula, which moisturises and spreads across the skin providing a breathable layer of protective cream (Beldon 2012). It has the following benefits:

  • 12-hour waterproof formulation: resists wash-off, provides long-lasting protection and reduces the amount of applications required (Fletcher, 2012)
  • Skin-friendly formulation: latex-free, fragrance-free, non-greasy and pH-balanced, making it a popular choice for people with sensitive skin (Fletcher, 2012)
  • Non-blocking formulation: doesn’t block incontinence pads (Fleming et al, 2014) and does not affect the adhesion of dressings or adhesive appliances 
  • Highly concentrated: small amounts can cover a large area of skin, improving cost-effectiveness (Fletcher, 2012)
  • Balanced consistency: the consistency is not too thick, making it easy to spread across the skin and form a breathable layer. This reduces the time taken to apply the cream and maximises coverage. After the cream has absorbed into the skin, no sticky residue is left
  • Choice: LBF Barrier Cream is available in three sizes - 2g sachet, 30g tube and 100g tube.​

LBF No Sting Barrier Film has been developed to protect skin from the harmful effects of bodily fluids such as urine, faeces, digestive enzymes and exudate. It will also protect against friction and adhesives. It has the following benefits:

  • Skin-friendly formulation: enjoy a no-sting experience thanks to the alcohol- free formulation.  The skin friendly formulation is also latex-, preservative- and fragrance-free
  • Transparency: the film allows visual inspection and monitoring of at-risk skin, whilst providing film flexibility for easy movement
  • Choice: the LBF No Sting Barrier Film is available in three applications.

LBF No Sting Barrier Film Spray

  • Comfortable application: it can be applied without touching the skin directly, which is ideal for sore and delicate skin
  • Easy to use: it provides 360⁰ dispensing and a uniform spray pattern for maximum coverage that can reach all areas, even when the can is upside-down, and is quieter than standard aerosols
  • Safe: there is no cold sensation when sprayed onto the skin, removing the potential risk of aerosol burns and discomfort
  • Economical: bag-on-valve technology delivers 100% active ingredient (no mixing with propellant) and avoids wastage
  • Choice: the spray is available in two sizes — 30ml and 50ml.

LBF Sterile No Sting Barrier Film Foam Applicator 

  • Sterile: the foam applicators are individually packaged for single use, and suitable for use on broken skin
  • Ease of application: the foam applicator allows for accurate application where precision is required
  • Choice: available in two sizes– 1ml and 2ml applicator.

LBF Sterile No Sting Barrier Film Wipes 

  • Clinically proven: the wipes are suitable for even the most sensitive skin and can be applied to broken skin
  • Sterile: the wipes are individually packaged for single use, and suitable for use on broken skin.

Available online at:
http://www.clinimed.co.uk/Wound-Care/Products.aspx

Available online at:
http://www.clinimed.co.uk/Stoma-Care/Products/Stoma-Skin-Care-and-Accessories/LBF/Detail.aspx

Indications

LBF No Sting Barrier Film Indications:

LBF No Sting Barrier Film is a liquid intended for external use as a film-forming product.  When applied to the skin, it forms a protective barrier between the skin and the corrosive bodily fluids, adhesive products and friction.  It is intended as a primary barrier against irritation from bodily fluids.  It can also provide an ideal surface for the adhesion of medical devices.

  • LBF No Sting Barrier Film Spray — for use on intact skin only
  • LBF Sterile No Sting Barrier Film Foam Applicator — single use application for use on both intact and broken skin
  • LBF Sterile No Sting Barrier Film Wipes — single use application for use on both intact and broken skin.

LBF Barrier Cream Indications

LBF Barrier Cream is indicated for the protection of skin that is at risk or likely to be compromised by corrosive bodily fluids (including urine, faeces, digestive enzymes), wound exudate, adhesives and friction. 

Contraindications

LBF No Sting Barrier Film Contraindications:

LBF No Sting Barrier Film Spray should not be used on broken or infected skin. 

LBF No Sting Barrier Film products are not to be used as the only covering in situations that require dressing protection from bacterial contamination/penetration, e.g. intravenous therapy catheter sites and full or partial thickness wounds.  It is not to be used on infected skin or in cases when there is a known allergic sensitivity to any of the ingredients. 

Do not use if packaging is damaged. 

LBF No Sting Barrier Film, in liquid form, is flammable; use in a well-ventilated area.  Avoid use around flames and sources of ignition.

LBF Barrier Cream Contraindications

LBF Barrier Cream is for external use and should not be used on broken or infected skin.  The cream should not be used in cases where there is a known allergic sensitivity to any of the ingredients.

Do not use if packaging is damaged. 

Product plus points

  • LBF Barrier Cream has a waterproof formulation that resists wash-off for 12-hours . This provides long-lasting protection and reduces the amount of applications needed (Beldon, 2012)
  • LBF Barrier Cream’s non-blocking formulation means it will not clog incontinence pads (Fletcher, 2012), ensuring pad absorbency is not reduced. Similarly, it will not affect the adhesion of dressings or medical devices such as stoma pouches. As it is highly concentrated, small amounts can cover a large area of skin, improving cost-effectiveness (Fletcher, 2012)
  • Recent studies have shown how the silicone-based films, such as LBF, outperformed zinc oxide preparations and had the advantage of being easier to apply (Neander and Hesse, 2003; Cameron et al, 2005)
  • LBF film products provide  an economical way of protecting vulnerable skin across the age spectrum (Voegeli, 2008)
  • LBF Barrier cream has a balanced consistency, making it easy to apply and spread effortlessly across the skin (Beldon, 2012); forming a breathable layer on application. This reduces the time taken to apply the cream and maximises coverage. After the cream has absorbed into the skin, no thick or sticky residue is left
  • Being latex-free, fragrance-free, non-greasy and pH-balanced, LBF Barrier Cream is also skin-friendly, making it a popular choice for people with sensitive skin, or those just wanting a more comfortable feel on their skin (Fletcher, 2012)
  • No Sting Barrier Film Spray has a bag-on-valve technology, allowing the film to be applied uniformly and preventing particles being sucked back into the canister, reducing risk of cross infection (Wounds UK, 2013). 

How to use

LBF Barrier Cream

In the case of continence care, the following steps should be taken:

  • Remove any urine or faecal matter
  • Cleanse and dry skin
  • Apply LBF Barrier Cream around the area as required
  • Repeat application after each incontinent episode or as required.

In the case of protection from adhesives and friction, the following steps should be taken:

  • Ensure the skin is clean and dry
  • Apply LBF Barrier Cream to intact skin around the area sparingly as required
  • Repeat application at each dressing/appliance removal or as required.

LBF No Sting Barrier Film Spray

  • Clean and dry the area where the barrier film is to be applied by removing any urine, faeces or wound exudate
  • Hold the spray nozzle 10–15cm (4–6 inches) from the intact skin and apply a smooth, uniform coating of film over the entire area, whilst moving the spray in a sweeping motion
  • The spray can be applied as required.  You should not need to remove the film as it will wear off naturally, however if removal is necessary a silicone medical adhesive remover such as Appeel Sterile can be used.

LBF Sterile No Sting Barrier Film Foam Applicator

  • Clean and dry the area where the barrier film is to be applied by removing any urine, faeces or wound exudate
  • Apply a uniform coating of film to the area using the foam applicator.  Each 1ml applicator will cover an area of at least 15cm x 15cm and the 2ml applicator will cover an area of at least 25cm x 25cm.

LBF Sterile No Sting Barrier Film Wipes

  • Clean and dry the area where the barrier film is to be applied by removing any urine, faeces or wound exudate
  • Apply the wipe evenly over the skin and allow it to dry for a few seconds.
  • Each wipe can cover a surface area of 15cm x 15cm.

Ordering information

CliniMed Product Code

Description

Quantity

PIP Code

NHS Supply Chain Code

3821

LBF Barrier Cream, 100g

1 tube

368-8397

GCC1398

3822

LBF Barrier Cream, 2g

1 box of 20 sachets

374-4307

GCC1396

3823

LBF Barrier Cream, 30g

1 tube

372-3335

GCC1397

3826

LBF No Sting Barrier Film Spray, 50ml

1 can

376-2200

ELY512

3827

LBF No Sting Barrier Film Spray, 30ml

1 can

376-2192

ELY475

3824

LBF Sterile No Sting Barrier Film Foam Applicator, 1ml

1 box of 5 foam applicators

376-2358

ELY474

3825

LBF Sterile No Sting Barrier Film Foam Applicator, 2ml

1 box of 5 foam applicators

390-2756

GCF295

3820

LBF Sterile No Sting Barrier Wipes

1 box of 30 wipes

289-6439

ELZ011

References


 

Beldon P (2012) Incontinence-associated dermatitis: protecting the older person. Br J Nurs 21(7): 402–07

Cameron J, Hoffman D, Wilson J, Cherry G (2005) Comparison of two peri- wound skin protectants in venous leg ulcers: a randomised controlled trial. J Wound Care 14(5): 233–36

Fleming L, Zala K & Ousey K (2014) Investigating the absorbency effects of LBF barrier cream. Wounds UK 10(2): 24-29

Fletcher J (2012) The use of a skin barrier cream in patients with incontinence. Wounds UK 8(1): 130–36

Neander KD, Hesse F (2003) The protective effects of a new preparation on wound edges. J Wound Care 12(10): 369–71

Wounds UK (2013) The use of skin barrier films in patients with moisture lesions. Clinical evaluation: LBF® No Sting Barrier Film. Wounds UK. Available online (accessed 27 July, 2013)

Evidence base

Beldon P (2012) Incontinence-associated dermatitis: protecting the older person. British Journal of Nursing 21(7): 402–407

This article examines older people’s skin and the way it is subject to dehydration, environmental factors and continence problems, which can lead to particularly painful incontinence-associated dermatitis (IAD), or even formation of moisture lesions. The author examines whether use of an effective barrier cream, which provides protection while not interfering with the efficiency of continence pads, can be an invaluable means of preventing IAD in older people.

The author outlines the pathophysiology of IAD in older patients as well as highlighting that quality of life studies demonstrate the detrimental effect of incontinence. She goes on to explain the benefits of skin assessment, skin cleansing and barrier creams, finally looking at recommendations for practice, which include using a barrier cream that contains dimethicone to provide an almost invisible barrier that does not affect the absorbency of body-worn continence pads.

The author provides three case studies of patients with urosepsis and associated skin damage; incontinence dermatitis owing to a combination of urinary and faecal incontinence; and Clostridium difficile and dehydration.

In each case the skin was improved through the use of LBF Barrier Cream, leading the author to conclude that the use of LBF Barrier Cream as part of a skin care regimen can ‘enhance the individual’s quality of life by providing protection from the deleterious effects of urine and faeces’.

Fleming L, Zala K, Ousey  K (2014)  Investigating the absorbency effects of LBF barrier cream. Wounds UK 10(2): 24–29

The authors explain that maintaining skin integrity and managing the microclimate around the skin in incontinence patients is of paramount importance.  They describe that when incontinence pads and barrier creams (both methods of protecting the skin from moisture contact) are used in conjunction, some reports have suggested the use of barrier creams will hinder the efficacy of incontinence products.  The study examined the effect of LBF barrier cream and three other commonly used barrier creams in two ways on the pads.  Firstly the amount of cream transferred to the incontinence pad from the patient’s skin and secondly the effects of that cream transfer on the capacity of the incontinence pad.

The study showed that LBF barrier cream was consistent with the other market-leading creams tested; the test indicated that LBF remained on the skin and was able to fulfil the role of providing a barrier to moisture for the skin.  Further testing with synthetic urine showed that in all cases the absorbency of the pads were affected by the barrier creams trialled, however the LBF barrier cream performed consistently and did not significantly impact the incontinence pads.

The authors concluded that there was cream transfer to incontinence pads in all four creams tested and a reduction in absorbency for all pads; however LBF performed favourably and the benefits of using an effective barrier cream outweigh the reduction of performance of incontinence pads, particularly when used in conjunction with higher absorbency pads.

Fletcher J (2012)  The use of a skin barrier cream in patients with incontinence.  Wounds UK 8(1): 30–36

This article examines the role skin plays in holistic health, providing a barrier against microbial invasion, minor trauma, chemical assault and dehydration. The author highlights how the skin can be damaged in a number of ways, one of which is incontinence.

Incontinence of urine, faeces or both can have a significant impact on the skin, most commonly resulting in incontinence-associated dermatitis (IAD). The author cites research suggesting that urine and faeces may cause damage to the skin individually, but that significant damage can occur when they are mixed.

When treating any patient with incontinence, preventing the development of IAD is paramount. The clinician must identify the cause of the incontinence and then catheters or faecal collection devices may be considered appropriate, particularly if the skin is very damaged and painful. Protecting and rehydrating the skin is also important using products such as barrier creams, skin protectors and emollients.

The author uses case studies of patients with spinal cord injuries to investigate a barrier cream’s ability to prevent skin breakdown. Following use of LBF Barrier Cream, all three patients showed improved skin colour and skin condition.

Voegeli D (2008)  LBF® ‘no-sting’ barrier wipes: skin care using advanced silicone technology. British Journal of Nursing 17(7): 472–76

Recently, there has been a growth in the use of silicone-based products, with various applications including disposable contact lenses, urinary catheters, and the development of innovative wound and skin care products.

The current development of topical silicone treatments to protect the skin reflects the need to protect vulnerable areas of patients’ skin and the prevent skin breakdown. These are basic principles of care that apply across the various specialties of care.

This article looks at how a silicone-based barrier film, such as CliniMed’s LBF No Sting Barrier Wipes, act to prevent and manage skin breakdown.

Beldon P (2013)  The use of skin barrier films in patients with moisture lesions. Clinical evaluation:  LBF® No Sting Barrier Film. Wounds UK.  2013. Available to download from:

http://www.wounds-uk.com/case-studies/the-use-of-skin-barrier-films-in-patients-with-moisture-lesions-clinical-evaluation-of-lbf-no-sting-barrier-film

(Last accessed 5th January 2015)

Excessive moisture on the skin can give rise to a plethora of problems, including maceration, incontinence-associated dermatitis and, in severe cases, moisture lesions. This damage can be caused by chronic wound exudate, urinary or faecal incontinence, or perspiration and the cost in human and financial terms can be considerable.

Moisture lesions result in a host of distressing symptoms including pain and discomfort and it is important that healthcare professionals are able to diagnose and manage it correctly.  This involves treating the cause of skin damage systemically as well as locally.

Clinicians have found barrier film useful in protecting the skin and keeping excess moisture from incontinence and wound fluid at bay.

This booklet highlights the damage caused by excessive moisture and uses case studies to investigate the efficacy of LBF No Sting Barrier Film.